scholarly journals Imaging therapy response of gastrointestinal stromal tumors (GIST) with FDG PET, CT and MRI: a systematic review

2017 ◽  
Vol 5 (3) ◽  
pp. 183-197 ◽  
Author(s):  
Antonia Dimitrakopoulou-Strauss ◽  
Ulrich Ronellenfitsch ◽  
Caixia Cheng ◽  
Leyun Pan ◽  
Christos Sachpekidis ◽  
...  
2017 ◽  
Vol 5 (6) ◽  
pp. 575-575
Author(s):  
Antonia Dimitrakopoulou-Strauss ◽  
Ulrich Ronellenfitsch ◽  
Caixia Cheng ◽  
Leyun Pan ◽  
Christos Sachpekidis ◽  
...  

Medicine ◽  
2018 ◽  
Vol 97 (16) ◽  
pp. e0389 ◽  
Author(s):  
Kongyuan Wei ◽  
Bei Pan ◽  
Huan Yang ◽  
Cuncun Lu ◽  
Long Ge ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-7 ◽  
Author(s):  
Alberto Zaniboni ◽  
Giordano Savelli ◽  
Claudio Pizzocaro ◽  
Pietro Basile ◽  
Valentina Massetti

The aim of the present paper is to review the scientific literature concerning the usefulness of18F-FDG PET/CT in the evaluation of response to chemotherapy in patients affected by liver metastases from colorectal cancer.Material and Methods. Studies were identified by searching PubMed electronic databases. Both prospective and retrospective studies were included. Information regarding the figure of merit of PET for the evaluation of therapy response was extracted and analyzed.Results. Existing data suggests that18F-FDG PET/CT may have an outstanding role in evaluating the response. The sensitivity of PET in detecting therapy response seems to be greater than conventional imaging (CT and MRI). PET/CT response is strictly related to better overall survival and progression-free survival.Conclusions. PET/CT is more than a promising technique to assess the response to chemotherapy in colorectal and liver metastases. However, to be fully validated, this examination needs further studies by recruiting more patients.


2012 ◽  
Vol 104 (7) ◽  
pp. 360-366 ◽  
Author(s):  
Eulalia Valls-Ferrusola ◽  
Juan Ramón García-Garzón ◽  
Ana Ponce-López ◽  
Marina Soler-Peter ◽  
Silvia Fuertes-Cabero ◽  
...  

2012 ◽  
Vol 81 (2) ◽  
pp. 303-311 ◽  
Author(s):  
Lian-Ming Wu ◽  
Fang-Yuan Chen ◽  
Xiao-Xing Jiang ◽  
Hai-Yan Gu ◽  
Yan Yin ◽  
...  

2020 ◽  
Vol 148 (1-2) ◽  
pp. 115-118
Author(s):  
Ljiljana Zivgarevic ◽  
Nebojsa Kozarevic ◽  
Svetlana Zunic

Introduction. Carney triad is a rare non-hereditary condition characterized by gastrointestinal stromal tumors ? intramural mesenchymal tumors of the gastrointestinal tract with neuronal or neural crest cell origin, pulmonary chondromas, and extra-adrenal paragangliomas. The term incomplete Carney triad more precisely refers to the occurrence of at least two of these tumor types. Carney triad named after J. Aidan Carney is considered to be a specific type of multiple endocrine neoplasia. Less than 30 cases of complete and less than 100 cases of incomplete Carney triad have been reported worldwide. Carney triad primarily affects young women (mean age of onset of 20 years). Case outline. A 35-year-old female patient had an initial presentation at the National PET Center, Clinical Center of Serbia, after the gastrectomy, with multiple hepatic metastases as well as bilateral pulmonary chondromas. 18F-FDG PET/CT scan revealed the following: 1) intense 18F-FDG uptake in the liver metastatic lesions, with reduced physiological activity in the brain and heart, bowel, and renal tracer uptakes commonly known as FDG hepatic superscan; 2) multiple irregular-shaped lesions, mostly calcified in bilateral pulmonary parenchyma; 3) a nodular lesion in the left adrenal gland with accumulation of 18F-FDG in its anterior part. Conclusion. The present study describes a hepatic superscan in a patient with incomplete Carney triad, including gastrointestinal stromal tumors and pulmonary bilateral chondromas, as well as a tumor in the left adrenal gland.


2010 ◽  
Vol 138 (5) ◽  
pp. S-660
Author(s):  
Masahiro Kogame ◽  
Atsushi Hiraoka ◽  
Naoto Kawaguchi ◽  
Makoto Kajihara ◽  
Tadashi Murakami ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document